Urticaria
📧 Sign up to get email alerts when something new happens for Urticaria.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Study to Compare Efficacy and Safety of TEV-45779 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria [Phase 3]
Phase 3 trial comparing TEV-45779 with Xolair (omalizumab) in adults with chronic idiopathic urticaria has completed and posted results on 2…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: COrticosteroids in acUte uRticAria in emerGency dEpartment [Phase 3]
This Phase 3 trial evaluating corticosteroids for acute urticaria in the emergency department has completed. The snippet does not report fin…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Extending Omalizumab Treatment Intervals in Patients With Chronic Spontaneous Urticaria [Phase 4]
Phase 4 clinical trial updating on extending omalizumab treatment intervals for chronic spontaneous urticaria; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Detection of Viral Particels in Urticaria Patients
A completed clinical trial investigated the detection of viral particles in patients with chronic urticaria.
-
FDA approval · 2025-08-29FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for cetirizine hydrochloride from Rising Pharma Holdings, Inc., indicating an update to the approved…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-08-22FDA Approved: DIPHENHYDRAMINE HYDROCHLORIDE — Original Application (Micro Labs Limited)
FDA approved a Diphenhydramine hydrochloride product from Micro Labs Limited under Original Application (ANDA 219845). This approval covers …
-
FDA approval · 2025-08-01FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for cetirizine hydrochloride from Sandoz Inc, granting regulatory clearance for this generic ant…
-
FDA label_change · 2025-07-28FDA Approved: QUZYTTIR — Supplemental Application (TerSera Therapeutics LLC)
FDA approves a supplemental application for QUZYTTIR (cetirizine hydrochloride) filed by TerSera Therapeutics, updating the product labeling…
-
FDA label_change · 2025-07-22FDA Approved: CHILDRENS XYZAL ALLERGY — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental labeling application for Children's XYZAL Allergy (levocetirizine dihydrochloride) by Chattem, Inc.
-
FDA approval · 2025-07-11FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for levocetirizine dihydrochloride (generic) submitted by Chartwell RX, LLC.
-
FDA label_change · 2025-07-11FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical's supplemental application for cetirizine hydrochloride, resulting in changes to the product labeling. C…
-
FDA approval · 2025-07-11FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for cetirizine hydrochloride from Padagis Israel Pharmaceuticals Ltd, confirming approval under a su…
-
FDA label_change · 2025-07-11FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for cetirizine hydrochloride, indicating a labeling or formulation-related update for the drug.
-
FDA approval · 2025-07-11FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Teva's levocetirizine dihydrochloride under an ANDA. The notice indicates an approved supplement…
-
FDA approval · 2025-07-11FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for cetirizine hydrochloride from Rising Pharma Holdings, Inc.
-
FDA approval · 2025-07-11FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for levocetirizine dihydrochloride, a generic antihistamine, under an ANDA.
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: To Compare and Evaluate the Oral Bioavailability of Bilastine 20 mg Orally Dispersible Tablet With That of Bilaxten (Bilastine) 20 mg Orally Dispersible Tablet in Healthy, Adult, Human Subjects Under Fasting Conditions [Phase 1]
Phase 1 study in healthy adults comparing the oral bioavailability of Bilastine 20 mg orally disintegrating tablet with Bilaxten (bilastine)…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Use of a Digital Psychotherapeutic App to Reduce Symptom Burden in Dermatology Patients [NA]
A clinical trial investigating a digital psychotherapeutic app aimed at reducing symptom burden in dermatology patients; the study is not ye…
-
EMA approval · 2025-05-28EMA Authorised: Xolair (omalizumab) — Novartis Europharm Limited
The European Medicines Agency authorised Xolair (omalizumab) for asthma, urticaria, and rhinitis with Novartis Europharm Limited as the mark…
-
FDA approval · 2025-05-14FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application to add a new chewable grape and bubblegum formulation of loratadine (Claritin) by Bayer HealthCare L…
-
FDA label_change · 2025-04-24FDA Approved: ZYRTEC HIVES — Supplemental Application (Kenvue Brands LLC)
FDA supplemental application for ZYRTEC HIVES to support labeling for cetirizine hydrochloride in the treatment of urticaria (hives).
-
CLINICAL_TRIALS research · 2025-04-18Clinical Trial Update: A Clinical Study to Assess the Safety and Effectiveness of Utixira Lotion and Utixira Tablet in Healthy Adult Human Subjects With Dry or Sensitive Skin Prone to Mild to Moderate Pruritus and Urticaria [NA]
A clinical trial update describing a study to assess the safety and effectiveness of Utixira Lotion and Utixira Tablet in healthy adults wit…
-
FDA approval · 2025-03-25FDA Approved: ZYRTEC HIVES — Supplemental Application (Kenvue Brands LLC)
The FDA approved a supplemental application for ZYRTEC HIVES (cetirizine hydrochloride) from Kenvue Brands LLC, indicating a label/indicatio…
-
FDA approval · 2025-03-13FDA Approved: ALLERGY RELIEF — Supplemental Application (Prodose, Inc)
FDA approved a supplemental application for ALLERGY RELIEF (cetirizine hydrochloride) by Prodose, Inc, authorizing a change under theANDA.
-
CLINICAL_TRIALS research · 2025-03-05Clinical Trial Update: Survey on the Characteristics of Traditional Medicine Syndromes in Urticaria Patients At Le Van Thinh Hospital
A clinical trial survey studying traditional medicine syndrome characteristics in patients with urticaria at Le Van Thinh Hospital.